# COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A

> **NCT05531019** · NA · COMPLETED · sponsor: **Fernando Saldarini** · enrollment: 54 (actual)

## Conditions studied

- Long COVID

## Interventions

- **DIETARY_SUPPLEMENT:** Echinochrome A
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT05531019
- **Lead sponsor:** Fernando Saldarini
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-22
- **Primary completion:** 2022-12-08
- **Final completion:** 2022-12-18
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05531019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05531019, "COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05531019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*